Table 3

Sensitivity analysis 1: the association of pneumonia as a primary diagnosis between birth and age 20 years and multiple sclerosis diagnosed over 20 years of age

Age groupCases n (%)Cont n (%)Model 1 OR (95% CI)*Model 2 OR (95% CI)*Model 3 OR (95% CI)*
Case definition 1†610949 479
Pneumonia
 0–542 (0.69)378 (0.76)0.89 (0.65 to 1.23)0.89 (0.64 to 1.23)0.88 (0.64 to 1.22)
 6–1014 (0.23)122 (0.25)0.92 (0.53 to 1.60)0.91 (0.52 to 1.58)0.91 (0.52 to 1.58)
 11–1515 (0.25)60 (0.12)2.00 (1.13 to 3.53)2.01 (1.14 to 3.54)2.00 (1.13 to 3.52)
 16–2015 (0.25)99 (0.2)1.25 (0.72 to 2.15)1.20 (0.70 to 2.08)1.18 (0.69 to 2.05)
IM
 0–56 (0.1)21 (0.04)2.14 (0.86 to 5.33)2.15 (0.86 to 5.36)
 6–109 (0.15)37 (0.07)1.90 (0.91 to 3.94)1.93 (0.93 to 4.01)
 11–1536 (0.59)106 (0.21)2.76 (1.89 to 4.04)2.76 (1.89 to 4.05)
 16–2051 (0.83)178 (0.36)2.28 (1.66 to 3.12)2.30 (1.68 to 3.15)
Case definition 2‡559243 327
Pneumonia
 0–537 (0.66)323 (0.75)0.88 (0.62 to 1.26)0.87 (0.62 to 1.24)0.87 (0.61 to 1.23)
 6–1013 (0.23)111 (0.26)0.87 (0.48 to 1.58)0.88 (0.48 to 1.59)0.88 (0.48 to 1.60)
 11–1512 (0.21)54 (0.12)1.78 (0.95 to 3.33)1.79 (0.96 to 3.35)1.78 (0.95 to 3.33)
 16–2013 (0.23)85 (0.2)1.08 (0.58 to 2.03)1.04 (0.55 to 1.96)1.02 (0.54 to 1.93)
IM
 0–55 (0.09)20 (0.05)1.57 (0.54 to 4.60)1.59 (0.54 to 4.67)
 6–109 (0.16)27 (0.06)2.35 (1.06 to 5.18)2.38 (1.08 to 5.26)
 11–1536 (0.64)93 (0.21)2.98 (2.01 to 4.44)2.99 (2.01 to 4.44)
 16–2047 (0.84)150 (0.35)2.33 (1.66 to 3.27)2.35 (1.67 to 3.29)
  • Bold text indicates results where the 95% CI does not cross 1.00.

  • *Model 1: adjusted for matching variables; model 2: adjusted for matching variables and IM; model 3: adjusted for matching variables, IM and education. In all models, the OR is comparing having a diagnosis within the age group with not having a diagnosis in the age group.

  • †Case definition 1: at least one MS diagnosis over age 20 years from the PR or MSR.

  • ‡Case definition 2: two or more MS diagnoses over age 20 years from the PR or diagnosis in the MSR.

  • Cont, controls; IM, infectious mononucleosis; MSR, Multiple Sclerosis Register; n, total individuals in group; PR, National Patient Register.